Tumor Necrosis Factor-α Gene Polymorphisms and Risk of Oral Cancer: Evidence from a Meta-analysis

  • Chen, Fang-Chun (Department of Oral Medicine, The Affiliated Hospital of Stomatology, Chongqing Medical University, Chongqing Key Laboratory for Oral Diseases and Biomedical Sciences) ;
  • Zhang, Fan (School of Public Health and Health Management, Department of Foreign Language, Chongqing Medical University) ;
  • Zhang, Zhi-Jiao (School of Public Health and Health Management, Department of Foreign Language, Chongqing Medical University) ;
  • Meng, Si-Ying (Department of Foreign Language, Chongqing Medical University) ;
  • Wang, Yang (School of Public Health and Health Management, Department of Foreign Language, Chongqing Medical University) ;
  • Xiang, Xue-Rong (Department of Oral Medicine, The Affiliated Hospital of Stomatology, Chongqing Medical University, Chongqing Key Laboratory for Oral Diseases and Biomedical Sciences) ;
  • Wang, Chun (Department of Oral Medicine, The Affiliated Hospital of Stomatology, Chongqing Medical University, Chongqing Key Laboratory for Oral Diseases and Biomedical Sciences) ;
  • Tang, Yu-Ying (Department of Oral Medicine, The Affiliated Hospital of Stomatology, Chongqing Medical University, Chongqing Key Laboratory for Oral Diseases and Biomedical Sciences)
  • Published : 2013.12.31


Numerous studies have been conducted regarding association between TNF-${\alpha}$ and oral cancer risk, but the results remain controversial. The present meta-analysis is performed to acquire a more precise estimation of relationships. Databases of Pubmed, the Cochrane library and the China National Knowledge Internet (CNKI) were retrieved until August 10, 2013. Pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated with fixed- or random-effect models. The heterogeneity assumption was assessed by I-squared test. Among the eight included case-control studies, all were focused on TNF-${\alpha}$-308G>A and four also concerned the TNF-${\alpha}$-238G>A polymorphism. It was found that oral cancer risk were significant decreased with the TNF-${\alpha}$-308G>A polymorphism in the additive genetic model (GG vs. AA, OR=0.19, 95% CI: [0.04, 1.00], P=0.05, I2=68.9%) and the dominant genetic model (GG+GA vs. AA, OR=0.22, 95% CI: [0.06, 0.82], P=0.03, I2=52.4%); however, no significant association was observed in allele contrast (G vs. A, OR=0.70, 95% CI: [0.23, 2.16], P=0.54, I2=95.9%) and recessive genetic models (GG vs. GA+AA, OR=0.72, 95% CI: [0.33, 1.57], P=0.41, I2=93.1%). For the TNF-${\alpha}$-238G>A polymorphism, significant associations with oral cancer risk were found in the allele contrast (G vs. A, OR=2.75, 95% CI: [1.25, 6.04], P=0.01, I2=0.0%) and recessive genetic models (GG vs. GA+AA, OR=2.23, 95%CI: [1.18, 4.23], P=0.01, I2=0.0%). Conclusively, this meta-analysis indicates that TNF-${\alpha}$ polymorphisms may contribute to the risk of oral cancer. Allele G and the GG+GA genotype of TNF-${\alpha}$-308G>A may decrease the risk of oral cancer, while allele G and the GG genotype of TNF-${\alpha}$-238G>A may cause an increase.


  1. Hohberger L, Wuertz BR, Xie H, Griffin T, Ondrey F (2008). TNF-alpha drives matrix metalloproteinase-9 in squamous oral carcinogenesis. Laryngoscope, 118, 1395-9.
  2. Jemal A, Bray F, Center MM, et al (2011). Global Cancer Statistics. CA Cancer J Clin, 61, 69-90.
  3. Jemal A, Siegel R, Xu JQ, et al (2010). Cancer Statistics, 2010. CA Cancer J Clin, 60, 277-300.
  4. Kaluza W, Reuss E, Grossmann S, et al (2000). Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol, 114, 1180-3.
  5. Kietthubthew S, Wickliffe J, Sriplung H, et al (2010). Association of polymorphisms in proinflammatory cytokine genes with the development of oral cancer in Southern Thailand. Int J Hyg Environ Health, 213, 146-52.
  6. Lee YH, Choi SJ, Ji JD, et al (2012). CTLA-4 and TNF-$\alpha$promoter-308 A/G polymorphisms and ANCA-associated vasculitis susceptibility: a meta-analysis. Mol Biol Rep, 39, 319-26.
  7. Leibovich SJ, Polverini PJ, Shepard HM, et al (1987). Macrophage-induced Angiogenesis is mediated by tumor necrosis factor-alpha. Nature, 6140, 630-2.
  8. Liu CJ, Wong YK, Chang KW, et al (2005). Tumor necrosis factor-$\alpha$ promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma. J Oral Pathol Med, 34, 608-12.
  9. Liu CM, Yeh CJ, Yu CC, et al (2012). Impact of interleukin-8 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan. Oral Diseases, 18, 307-14.
  10. Liu L, Yang X, Chen XJ, et al (2012). Association between TNF-$\alpha$ polymorphisms and cervical cancer risk: a metaanalysis. Mol Biol Rep, 39, 2683-8.
  11. Lu D, Yu XD, Du YK (2011). Meta-analyses of the effect of cytochrome P450 2E1 gene polymorphism on the risk of head and neck cancer. Mol Biol Rep, 38, 2409-16.
  12. Lu Z, Chen L, Li H, et al (2008). Effect of the polymorphism of tumor necrosis factor-$\alpha$-308 G/A gene promoter on the susceptibility to ulcerative colitis: a meta analysis. Digestion, 78, 44-51.
  13. Machado JC, Figueiredo C, Canedo P, et al (2003). A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology, 125, 364-71.
  14. Malleo G, Mazzon E, Siriwardena AK, et al (2007). Role of tumor necrosis factor-$\alpha$ in acute pancreatitis: from biological basis to clinical evidence. Shock, 28, 130-40.
  15. Marsh HP, Haldar NA, Bunce M, et al (2003). Polymorphisms in tumor necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumor at presentation. Br J Cancer, 89, 1096-101.
  16. Mestiri S, Bouaouina N, Ahmed SB, et al (2001). Genetic variation in the tumor necrosis factoralpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. Cancer, 91, 672-8.<672::AID-CNCR1050>3.0.CO;2-J
  17. Carswell EA, Old LJ, Kassel RL, et al (1975). An endotoxininduced serum factor that causes necrosis of tumors. Proc Natl Acad Sci, 9, 3666-70.
  18. Chen WC, Tsai MH, Wan L, et al (2005). CYP17 and tumor necrosis factor-a gene polymorphisms are associated with risk of oral cancer in Chinese patients in Taiwan. Acta Oto-Laryngologica, 125, 96-9.
  19. Cheng K, Zhao YJ, Liu L, Wan JJ (2013). Tumor necrosis factor-$\alpha$ 238 G/A polymorphism and risk of hepatocellular carcinoma: evidence from a meta-analysis. Asian Pac J Cancer Prev, 14, 3275-9.
  20. Chiu CJ, Chiang CP, Chang ML, et al (2001). Association between genetic polymorphism of tumor necrosis factoralpha and risk of oral submucous fibrosis, a pre-cancerous condition of oral cancer. J Dent Res, 80, 2055-9.
  21. de Luis DA, Sagrado MG, Vallejo LA, et al (2007). Influence of G308A polymorphism of tumor necrosis factor-$\alpha$ gene on inflammatory markers in postsurgical head and neck cancer patients with early enteral nutrition. Nutrition, 23, 529-32.
  22. Dinarello CA, Wolff SM (1993). The role of interleukin-1 in disease. N Engl J Med, 2, 106-13.
  23. Farkas G Jr, Hofner P, Balog A, et al (2007). Relevance of transforming growth factor-$\beta$1, interleukin-8, and tumor necrosis factor-$\alpha$polymorphisms in patients with chronic pancreatitis. Eur Cytokine Netw, 18, 1-7.
  24. Govan VA, Constant D, Hoffman M, et al (2006). The allelic distribution of -308 tumor necrosis factor-alpha gene polymorphismin South African women with cervical cancer and control women. BMC Cancer, 6, 24.
  25. Gupta R, Sharma SC, Das SN (2008). Association of TNF-$\alpha$ and TNFR1 promoters and 30 UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians. Oral Oncol, 44, 455-63.
  26. Miriam HR, Natalia RB, Xabier MM, et al (2012). Role of cytochrome P-450 genetic polymorphisms in oral carcinogenesis. J Oral Pathol Med, 41, 1-8.
  27. Moonesinghe R, Khoury MJ, Janssens AC (2007). Most published research findings are false-but a little replication goes a long way. PLoS Med, 2, e28.
  28. Moonesinghe R, Khoury MJ, Liu T, et al (2008). Required sample size andnonreplicability thresholds for heterogeneous genetic associations. Proc Natl Acad Sci, 2, 617-22.
  29. Nakajima K, Sasaki M, Nojima D, et al (2001). Tumor necrosis factor-alpha gene mutations and genotype changes in renal cell carcinoma. J Urol, 165, 612-5.
  30. Overton RC (1998). A comparison of fixed-effects and mixed (random-effects) models for meta-analysis tests of moderator variable effects. Psychol Methods, 3, 354-79.
  31. Pavy S, Toonen EJ, Miceli-Richard C, et al (2010). Tumor necrosis factor $\alpha$-308 GgA polymorphism is not associated with response to TNF-$\alpha$ blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis. Ann Rheum Dis, 69, 1022-28.
  32. Petersen PE (2009). Oral cancer prevention and control-The approach of the World Health Organization. Oral Oncol, 45, 454-60.
  33. Petersen PE (2005). Strengthening the prevention of oral cancer: the WHO perspective. Community Dent Oral Epidemiol, 33, 397-9.
  34. Powell JJ, Fearon KCH, Siriwardena AK, et al (2001). Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis. Surgery, 129, 633-40.
  35. Sasieni PD (1997). From genotypes to genes: doubling the sample size. Biometrics, 53, 1253-61.
  36. Serefoglou Z, Yapijakis C, Nkenke E, et al (2008). Genetic association of cytokine DNA polymorphisms with head and neck cancer. Oral Oncol, 44, 1093-9.
  37. Shih CM, Lee YL, Chiou HL, et al (2006). Association of TNFalpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer, 52, 15-20.
  38. Shukla D, Dinesh KA, Hallikerimath S, et al (2012). Genetic polymorphism of drug metabolizing enzymes (GSTM1 and CYP1A1) as risk factors for oral premalignant lesions and oral cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 156, 253-9.
  39. Silverman S Jr. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc, 132, S7-11.
  40. Tracey KJ, Cerami A (1993). Tumor necrosis factor, other cytokines and disease. Ann Rev Cell Biol, 9, 317-43.
  41. Tsigris C, Chatzitheofylaktou A, Xiromeritis C, Nikiteas N, Yannopoulos A (2007). Genetic Association Studies in Digestive System Malignancies. Anticancer Res, 27, 3577-88.
  42. Vairaktaris E, Yapijakis C, Serefoglou Z, et al (2008). Gene expression polymorphisms of interleukins-1b, -4, -6, -8, -10, and tumor necrosis factors-a, -b: regression analysis of their effect upon oral squamous cell carcinoma. J Cancer Res Clin Oncol, 134, 821-32.
  43. Williams HK (2000). Molecular pathogenesis of oral squamous Carcinoma. J Clin Pathol:Mol Pathol, 53, 165-72.
  44. Wu HC, Chang CH, Chen HY, et al (2004). p53 gene codon 72 polymorphism but not tumor necrosis factor-alpha gene is associated with prostate cancer. Urol Int, 73, 41-6.
  45. Yang CM , Hou YY , Chiu YT, et al (2011). Interaction between tumor necrosis factor-$\alpha$ gene polymorphisms and substance use on risk of betel quid-related oral and pharyngeal squamous cell carcinoma in Taiwan. Archives of Oral Biol, 56, 1162-9.
  46. Yapijakis C, Serefoglou Z, Vylliotis A, et al (2009). Association of Polymorphisms in Tumor Necrosis Factor Alpha and Beta Genes with Increased Risk for Oral Cancer. Anticancer Res, 29, 2379-86.
  47. Zeggini E, Ioannidis JP (2009). Meta-analysis in genome-wide association studies. Pharmacogenomics, 2, 191-201.
  48. Zhou CC, Zhou Y, Li J, et al (2009). The Arg194Trp polymorphism in the X-ray repair cross-complementing group 1 gene as a potential risk factor of oral cancer: a metaanalysis. Tohoku J Exp Med, 219, 43-51.
  49. Zhuo XL, Li Q, Zhou Y, et al (2009). Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility. Arch Med Res, 40, 625-34.
  50. Zintzaras E, Ioannidis JP (2005). Heterogeneity testing in meta analysis of genome searches. Genet Epidemiol, 2, 123-37.

Cited by

  1. Association of Serum and Salivary Tumor Necrosis Factor-α with Histological Grading in Oral Cancer and its Role in Differentiating Premalignant and Malignant Oral Disease vol.15, pp.17, 2014,
  2. Pro-(IL-18) and Anti-(IL-10) Inflammatory Promoter Genetic Variants (Intrinsic Factors) with Tobacco Exposure (Extrinsic Factors) May Influence Susceptibility and Severity of Prostate Carcinoma: A Prospective Study vol.16, pp.8, 2015,
  3. PPI-G4 Glycodendrimers Upregulate TRAIL-Induced Apoptosis in Chronic Lymphocytic Leukemia Cells vol.17, pp.5, 2016,